Albumin Market Regional Share
The Albumin Market consists of three main types: human serum albumin (HSA), bovine serum albumin (BSA), and recombinant albumin.
Human serum albumin is derived from human plasma and widely used in clinical settings for treating burns, trauma, and liver diseases. Its compatibility with human physiology makes it ideal for critical care, though supply is dependent on plasma donations.
Bovine serum albumin is used extensively in research, diagnostics, and industrial applications. It offers excellent protein stability and is widely available at lower cost than human albumin.
Recombinant albumin, produced via genetic engineering, is gaining popularity due to its safety, scalability, and pathogen-free nature. It is particularly valued in biopharmaceutical manufacturing, cell therapy, and regenerative medicine.
The choice of albumin type depends on application needs, regulatory requirements, and cost considerations. Market trends indicate growing adoption of recombinant variants as production technology becomes more cost-efficient and widely available.